Kevin P. Regan
FDA Investigator
- Kevin P. Regan first started conducting FDA inspections in 2021, with the last inspection in 2024. Over that time, Kevin P. Regan has conducted 21 inspections at 20 companies across 20 sites.
Get Kevin Regan's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Mylan Laboratories Limited, Hosur | 2024
Out of stock
FDA 483 Alaina Healthcare Private Limited, Baddi | 2024
Out of stock
FDA 483 IntegraDose Compounding Services LLC, Minneapolis | 2024
Out of stock
FDA 483 HQ Pharma (Shanghai) Co., Ltd., Shanghai | 2023
Out of stock
FDA 483 Ningbo Shuangcheng Pharmaceutical Co., Ltd., Ningbo | 2023
Out of stock
FDA 483 Zhejiang Clairvoyant Pharmaceutical Technology Co., Ltd., Hangzhou | 2023
Out of stock
FDA 483 Nanjing MilestonePharma Co. Ltd., Nanjing | 2023
Out of stock
FDA 483 Shandong Zouping Dazhan New Materials Co., Ltd., Zhouping | 2023
Out of stock
FDA 483 Yichang Humanwell Oral Solid Dosage Plant, Yichang | 2023
Out of stock
FDA 483 Intervet International GmbH, Unterschleisheim | 2023
Out of stock
FDA 483 L'Oreal Usa, Inc., Florence | 2022
Out of stock
FDA 483 Upsher-Smith Laboratories, LLC, Maple Grove | 2022
Out of stock
FDA 483 CHRI Laboratories, Inc., Saint Paul | 2022
Out of stock
FDA 483 LSNE Contract Manufacturing a PCI Pharma Services Company, Madison | 2022
Out of stock
FDA 483 Padagis US LLC, Minneapolis | 2022
Out of stock
Co-Investigators (13)
- Patty P. Kaewussdangkul, FDA Investigator
- Robert J. Ham, FDA Investigator
- Melissa M. Steiger, FDA Investigator
- Soyinka S. Eneng, FDA Investigator
- Beatrix D. Arevalo, FDA Investigator
- Beatrix D. Hippe, FDA Investigator
- Timothy H. Vo, FDA Investigator
- Alan P. Kurtzberg, FDA Investigator
- Ross J. Grigsby, FDA Investigator
- Sandra A. Boyd, FDA Investigator
- Lori B. Wikstrom, FDA Investigator
- Anthony J. Ladner, FDA Investigator
- Michele L. Glendenning, FDA Investigator